logo
Products
Services
Resources
Selection Guides
About
iFluor® 750 Anti-human CD200 Antibody
OX-104
OX-104 is an anti-human monoclonal antibody that forms an immune complex with the CD200 antigen. CD200 (sometimes referred to as OX-2 or OX2) is a single-pass type i membrane protein that is expressed on the surface of cells like stem cells, dendritic cells, B cells and endothelial cells. CD200 has been thought to be involved with vital biological processes such as cell-cell adhesion, especially heterotypic cell-cell adhesion. In addition, in many organisms, it suppresses neuron death, is a negative regulator of macrophage activation and is a negative regulator of interleukin-6 secretion. From a research standpoint, it is of biological interest due to its association with important macromolecules/ligands such as CD200R1. CD200 is a fairly uncommon antibody target, with a little more than 2000 publications in the last decade. Even still, CD200 is commonly used in flow cytometry applications as a phenotypic marker for differentiation of cell types, specifically in the study of neuroscience and immunology. This antibody was purified through affinity chromatography and conjugated to iFluor® 750 (ex/em = 757/779 nm).
product image
CatalogSize
Price
Quantity
120000L0100 tests
Price
120000L1500 tests
Price
 
Antibody properties

Other namesOX-2
CloneOX-104
HostMouse
IsotypeIgG1, kappa
ReactivityHuman
ApplicationFlow Cytometry (FACS), Fluorescence Imaging
Spectral properties

Correction factor (260 nm)0.044
Correction factor (280 nm)0.039
Correction factor (565 nm)0.0250
Correction factor (650 nm)0.1413
Extinction coefficient (cm -1 M -1)
275000
1
Excitation (nm)757
Emission (nm)779
Quantum yield
0.12
1
Usage and storage

Intended useResearch Use Only (RUO)
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on August 8, 2026